Skip to main content

EDITORIAL article

Front. Physiol., 14 March 2023
Sec. Integrative Physiology
This article is part of the Research Topic Molecular Physiology of Tissue Adaptation to Acute Ischemic Injury View all 5 articles

Editorial: Molecular physiology of tissue adaptation to acute ischemic injury

  • 1A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia
  • 2Department of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
  • 3Institute of Physiologically Active Compounds, Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry of the RAS, Chernogolovka, Russia

Ischemia is a condition of reduced blood flow to tissues, which is often followed by a detrimental reperfusion process upon restoration of blood flow (Wu et al., 2018). Ischemia/reperfusion (I/R) injury can affect any organ and lead to critical pathological conditions such as ischemic stroke, myocardial infarction (MI), acute kidney injury (AKI), and others (Eltzschig and Eckle, 2011). Despite active research in this field, not all the molecular mechanisms and consequences of I/R have been fully disclosed, which impedes the development of effective and timely treatments.

One of the most pronounced effects of I/R injury is the change in gene expression in the cells of damaged tissue. Regarding this, He et al. performed comprehensive bioinformatic analysis of two datasets containing mRNA expression profiles of kidney cells after I/R exposure. The study revealed that the majority of differentially expressed genes were upregulated in the I/R group and reflected the processes of inflammation and apoptosis. Bioinformatic analysis found ten hub genes, including Jun, Stat3, MYC, Cdkn1a, Hif1a, FOS, Atf3, Mdm2, Egr1, and Ddit3, which may become useful biomarkers of AKI at the early stages. Interaction networks were also constructed, which helped to predict transcription factors and mi-RNAs that may interact with discovered hub genes and signaling pathways. Moreover, authors proposed molecular compounds that may be efficient in the therapy of AKI.

Since the lack of appropriate therapy of ischemic pathologies, new approaches and drugs are being actively developed. Osthole is suggested as a promising drug for AKI treatment. Osthole is a natural coumarin from Cnidium monnieri, which has proven its anti-inflammatory, immunomodulatory, and anti-cancer effects in different organs by regulating PI3K/Akt signaling pathway. Dai et al. showed that osthole inhibited HMGB1 gene transcription and protein synthesis, reduced its acetylation and release from the nucleus into cytoplasm and extracellular space, which may be the main reason for its nephroprotective effects during renal I/R.

A dangerous complication of ischemic pathologies is that I/R injury of one organ can lead to multi-organ damage. For instance, ischemic AKI may provoke pancreatic injury and disrupt insulin production by causing the death of beta cells. To preserve the functioning of pancreas during renal I/R, ShamsEldeen et al. tested therapy based on bone marrow mesenchymal stem cells and nicorandil administration. Nicorandil is a mitochondrial K-ATP channel opener, which also acts as nitric oxide donor. Opening of K-ATP channels by nicorandil may lead to hyperpolarization of the beta cells and prevent insulin release during renal I/R-induced pancreatic injury. Indeed, combined systemic nicorandil administration and nicorandil-preconditioned mesenchymal stem cells maintained the most pronounced survival of pancreatic tissue and ameliorated apoptosis and inflammation through activation of PI3K/Akt/mTOR signaling pathway.

Multi-organ damage is also a common consequence of MI. Wang et al. observed the influence of cardiac I/R injury on visceral and subcutaneous white adipose tissue. Since adipose tissue is an important endocrine organ that secretes a range of adipokines, cytokines, and micro-RNAs, its functioning during and after ischemic exposure is of great interest. To unravel the effects of MI on fat depots, authors monitored morphology, cellular infiltrates, and gene expression of adipocyte cells for 28 days post ischemia. They demonstrated that cardiac I/R led to a decrease in adipocyte size in subcutaneous, but not visceral white adipose tissue, indicating more pronounced susceptibility of subcutaneous fat depots to MI. Moreover, after cardiac I/R, subcutaneous adipose tissue showed reprogramming to brown-like phenotype, higher macrophage infiltration, and a reduction in adipokine gene expression.

Conclusion

Diseases associated with I/R injury are characterized by high morbidity, mortality, and healthcare costs and represent a global public health concern. The articles collected in the Research Topic aimed to gain an understanding of molecular mechanism of renal and cardiac I/R, as well as to identify potential molecular markers and drug targets for the treatment. Eventually, the studies found hub genes activated during ischemic injury, discovered osthole and nicorandil as promising therapeutic compounds, analyzed kidney–pancreas and heart–adipose tissue crosstalks. We hope that in-depth research based on these findings will open up new therapeutic strategies in the prevention and treatment of ischemic pathologies.

Author contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Acknowledgments

EP is a member of the Scientific and Education School Molecular Technologies of live systems and synthetic biology at the Moscow State University.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Eltzschig H. K., Eckle T. (2011). Ischemia and reperfusion--from mechanism to translation. Nat. Med. 17, 1391–1401. doi:10.1038/nm.2507

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu M.-Y., Yiang G.-T., Liao W.-T., Tsai A. P.-Y., Cheng Y.-L., Cheng P.-W., et al. (2018). Current mechanistic concepts in ischemia and reperfusion injury. Cell. Physiol. biochem. 46, 1650–1667. doi:10.1159/000489241

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: ischemia, kidney, heart, mesenchymal stem cells, nicorandil, hub genes, white adipose tissue, osthole

Citation: Plotnikov E, Krivtsov A and Ustyugov A (2023) Editorial: Molecular physiology of tissue adaptation to acute ischemic injury. Front. Physiol. 14:1179083. doi: 10.3389/fphys.2023.1179083

Received: 03 March 2023; Accepted: 08 March 2023;
Published: 14 March 2023.

Edited and reviewed by:

Geoffrey A. Head, Baker Heart and Diabetes Institute, Australia

Copyright © 2023 Plotnikov, Krivtsov and Ustyugov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Egor Plotnikov, plotnikov@belozersky.msu.ru; Andrei Krivtsov, andrei_krivtsov@dfci.harvard.edu; Aleksey Ustyugov, alexey@ipac.ac.ru

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.